TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PLASMINCHEN

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

PLASMINCHEN

ST13

US500000079407754

Classe

5, 35, 42, 44

Pedido

79407754

Registro

7910352

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

22/05/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 35, 42, 44

Data de depósito

21/06/2024

Data de registro

26/08/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

26/08/2025

Última transação

22/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

99

Localização do titular

DE

Examinador

CORWIN, KEVIN SCOTT

Unidade examinadora

M30

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of the stylized wording "PLASMINCHEN" appearing below the design of an anthropomorphic blood donation bag having human-like arms, feet, eyes, and mouth.

Titulares e representantes

Titulares

Haema GmbH
Haema AG

Representantes

Deborah L. Shapiro Moses & Singer LLP

Classificação técnica

Classes Nice

Classe 5Classe 35Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Medicines, in particular medicines made from blood components, fractions and preparations, with said medicines being for the treatment of diseases and disorders of the blood; Blood components, fractions and preparations, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; Blood components, fractions and preparations for injection, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; Blood components, fractions and preparations for automatic transplantation, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; Blood components, fractions and preparations for transfusion, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; Blood components, fractions and preparations for immunotherapy, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; Blood components, fractions and preparations for autologous transfusion, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; Blood, blood fractions and blood components for medical, therapeutic, and prophylactic purposes, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; Blood plasma; Cells for medical use, namely, blood cell preparations; Health care substances and preparations, in particular for haematology, namely, pharmaceuticals for the treatment of blood diseases and disorders, blood for medical purposes, blood plasma, and blood substitutes for human use; Finished medical products, namely, blood for human use and blood plasma; Preparations for medical purposes, in particular haematology preparations namely, pharmaceuticals for the treatment of blood diseases and disorders, blood for medical purposes, blood plasma, and blood substitutes for human use; Immunotherapeutic and immunoprophylactic preparations, namely, pharmaceuticals for treating immunological diseases and disorders; Living cells for medical purposes, namely, leukocyte preparations of white blood cells; Living cells and cell fragments for medical purposes, namely, platelet and red blood cell concentrates; Blood plasma, namely, quarantine plasma and fractionated plasma; Clinical medical reagents for processing human blood and blood components for use in blood transfusions and for extracorporeal blood processing stored in bags, bottles, syringes and similar containers for storing substances such as these for medical purposes; Pharmaceutical products and haematology preparations including those for the treatment of blood and blood components, in particular infusion and transfusion solutions in the nature of blood, blood plasma, and blood substitutes for human use and pharmaceuticals for the treatment of blood diseases and disorders; Pharmaceutical blood plasma preparations for the treatment of blood diseases, blood disorders; Pharmaceutical blood preparations for the treatment of blood diseases, blood disorders; Pharmaceutical blood products, namely, pharmaceuticals for the treatment of blood diseases, blood disorders; Cell material for autotransplantation and autotransfusion, cells for medical use; Cell material for transplantation and transfusion, namely, cells for medical use; Cell material for medical, therapeutic and prophylactic purposes, namely, cells for medical purposes

Classe 35

Updating and maintenance of blood donor data in computer databases; Maintenance of computer databases, namely, maintenance of blood donor databases for others

Classe 42

Technical provision and support for data processing systems, namely, providing technology information in the field of data processing and technical support services in the nature of troubleshooting computer software problems in connection with data processing; Providing temporary use of online, non-downloadable software for accessing patient treatment databases and donor databases; Providing technological and scientific information about scientific laboratory services and blood banks, in particular medical research laboratories; Providing of scientific information derived from analysis of medical diagnostic results; Blood analysis services for scientific research purposes; Scientific laboratory services; Chemical laboratories and medical research laboratories; Scientific research in the field of physics; Chemistry services, namely, chemical analysis, chemical laboratories; Chemical analysis; Scientific testing services, namely, blood testing for scientific research purpose; Blood testing for scientific research purposes, with said testing entailing the filtration, separation and centrifugation of blood; Laboratory trials, namely, medical and scientific research in the nature of conducting clinical trials for others; Development and further development of data processing computer software and hardware in the field of laboratory medicine and blood and plasma collection; Database development services, namely, creation of medical databases in digital form; Scientific and medical research in the medical and pharmaceutical fields; Scientific and medical research in the field of chemistry and biology; Development and establishment of testing specifications and procedures for the medical industry, namely, development of medical equipment procedures and test procedures, donation procedures, and medical instrument procedures; Data processing services, namely, technical and scientific registration and processing of patient treatment data and donor data in databases; Scientific laboratory services

Classe 44

Medical analysis services for diagnostic and treatment purposes provided by medical laboratories in connection with blood and plasma donation and clinical medical consultations in connection with the same; Clinical medical consultation services in relation to transfusion medicine; pharmacy advice; Providing of medical information in relation to blood donation centres; Providing of medical and pharmaceutical support via telephone, namely, providing medical information generally; Medical services featuring blood fractionation or treatment; Medical services in the nature of blood sampling and collection; blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Pharmacy services, namely, preparation of prescriptions in pharmacies; Medical assistance; Blood bank services; Blood bank services in the nature of blood donation centres; Blood bank services in the nature of blood extraction stations; Services in the field of immunotherapy, namely, medical care; Consulting services in the field of medical care, namely, consultancy in relation to transfusion medicine and clinic hygiene, medical transfusion consultancy in clinics, in particular consultancy by doctors administering transfusions, medical transfusion testing; Medical care, namely, immunotherapy; Providing medical information, namely, medical diagnostic information through medical results; Medical care, namely, conducting medical diagnostics within the framework of conducting medical examinations; Blood bank services, namely, collecting of blood donations, including platelet donations, SDR donation being erythrocyte donation, whole blood donation, plasma donation, and autologous donation being multiple types of cellular donations from an individual; Medical care, namely, execution of medical and clinical examination services; Dietetic advisory services; Providing medical opinions in the nature of medical advice in the field of weight loss, dermatology, hematology; Health counselling; Medical care, namely, transfusion or transplantation of blood and blood components; Medical services; Medical care, namely, the use of medical equipment, instruments and apparatus for medical care purposes; Blood bank services, namely, services of packed red blood cell banks; Blood bank services, namely, services of platelet concentrate banks; Blood bank services, namely, services of leukocyte banks; Blood bank services, namely, services of blood plasma banks and collection and preservation of blood for medical and diagnostic purposes; Blood bank services, namely, blood component banks; Medical services, namely, extraction of stem cells; Remote monitoring of medical data for medical diagnosis and treatment, namely, monitoring of blood donor databases for the aforementioned purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

21/05/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

09/04/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

23/03/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

23/03/2026

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

14/03/2026

XXCR

GENERIC MADRID TRANSACTION CREATED

14/03/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

26/11/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

26/08/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

26/08/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/07/2025

PUBO

PUBLISHED FOR OPPOSITION

08/07/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/07/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/06/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/06/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/06/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/06/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

18/04/2025

RFNT

REFUSAL PROCESSED BY IB

15/02/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

27/01/2025

RFRR

REFUSAL PROCESSED BY MPU

27/01/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

27/12/2024

CNRT

NON-FINAL ACTION WRITTEN

26/12/2024

DOCK

ASSIGNED TO EXAMINER

21/12/2024

MAFR

APPLICATION FILING RECEIPT MAILED

27/10/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

27/10/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

24/10/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PLASMINCHEN ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.